First-visit guide
What to expect at your first GLP-1 telehealth appointment.
A walkthrough of a typical first GLP-1 telehealth consultation — how to set up the intake form so the call goes smoothly, what a legitimate prescriber asks in the room, how fast the prescription actually reaches the pharmacy once the visit closes, and the follow-up rhythm to budget for after the first dose ships. Intended for shoppers who are still choosing between the storefronts on the providers index and want to know what they are signing up for.
1. Before the visit: health history & labs to have ready.
The intake form is where most of the clinical work actually happens, and it goes faster if you arrive with the answers in front of you. A legitimate storefront walks you through a few predictable fields before scheduling the consult: your current medications (including any supplements and recent antibiotics), a recent weight trend rather than a single number, your most recent HbA1c and lipid panel if you have them, and any thyroid history — personal or family — that could matter for a GLP-1 decision. If a thyroid cancer history sits in your family, say so; a medullary thyroid carcinoma history in you or a first-degree relative is a contraindication the prescriber needs to see up front, not at the pharmacy window.
You do not need to bring physical lab printouts. If your labs live in a patient portal from your primary care provider, the prescriber reads them on the call; if you do not have recent labs, a legitimate program orders them as part of the intake rather than skipping past the question. A storefront that asks for weight, height, and a credit card and skips the rest of the intake is not running a clinical consult — it is running a checkout flow. Confirm in advance which providers on the index run a real clinician-led intake, not a checkbox form.
2. What the prescriber will ask.
The consult itself is a clinician-led conversation, not a sales pitch. Expect the prescriber — a physician, nurse practitioner, or physician assistant, licensed in the state where you physically sit during the call — to verify your BMI threshold for therapy, walk through your prior weight-loss attempts (what you have tried, what worked, what did not), review your comorbidities (hypertension, sleep apnea, pre-diabetes), and confirm there are no contraindications on file. The clinician should name themselves, name the state that licenses them, and be willing to share their NPI or board-lookup details on request. If they cannot or will not, that is the same licensure thing we covered in the provider verification guide: the prescription is only valid if the prescriber holds an active license in the state where you are sitting during the visit.
Expect the visit to feel like a primary-care intake, not a sales call. The legitimate question on the other end is whether GLP-1 therapy is clinically appropriate for you and which starting dose fits — not whether you are ready to commit to a six-month bundle. A storefront that pushes you toward a longer subscription inside the consult, refuses to discuss dose escalation explicitly, or rushes you off the call without answering tolerability questions is selling a contract, not running a practice.
3. How quickly the prescription reaches the pharmacy.
After the consult closes, the prescription lands at the pharmacy the provider uses and the fulfillment clock starts. Most legitimate storefronts ship same-day or next business day from a 503A compounding pharmacy (each vial made for an individual prescription, typically 2–5 business days to your door) or a 503B outsourcing facility (batch-made under FDA-style manufacturing standards, often faster because inventory sits on the shelf). Which path matters because it drives both the price you were quoted and how quickly the package arrives. Brand-name semaglutide or tirzepatide ships from the manufacturer’s own FDA-approved supply chain on the pharmacy’s standard schedule, not next-day.
The honest framing is that shipping speed is one of the things you compare when you line providers up against each other. The head-to-head comparison surfaces shipping window, pharmacy type, and lead time side by side with pricing, so a two-day shipping promise and a seven-day compounding window stop looking the same once the actual clock is in front of you. Ask which pharmacy the provider uses, whether it is licensed in your state, and what the realistic arrival window looks like before you commit to a bundle.
4. Follow-up cadence.
GLP-1 therapy is titrated, which means the dose goes up over the first two months as your body tolerates it, and the program has to be set up to support that. A typical cadence looks like this: weeks 1–4 on a starter dose to gauge tolerability, weeks 5–8 a step-up to the next dose tier, then monthly check-ins once you hit the maintenance dose that your clinician settles on. Side-effect check-ins sit inside that cadence — nausea, reflux, constipation, and anything more worrying — usually through asynchronous messaging with the named clinician, not a shared support inbox.
The refill loop matters as much as the dose tier. Most legitimate programs schedule refills against a clinician sign-off rather than an auto-shipped calendar, so each refill is a chance to revisit dose, side effects, and whether the original goal is on track. The comparison surface treats the support model as part of the offer itself, alongside price and pharmacy type, because how the follow-up actually runs is what determines whether the program survives past month three.